On Episode 32 of The HQ Podcast, we're pleased to be joined by Dr.

Christopher McCabe, Professor of Health Economics at Queens University in

Belfast, Northern Ireland, and renowned health economics leader. During our

conversation, we discuss the notion of "value" as it relates to

healthcare (what it is, why it's important, how we measure it) and the crucial

questions that need to be asked when it comes to designing or re-building a

healthcare system that not only produces the best outcomes for taxpayers but

also considers the critical health professionals who ultimately will deliver

the healthcare priorities that Canadians need to agree upon.

Tune in for an engaging and thought-provoking conversation that will leave

you with a deeper understanding of healthcare economics, value and the

questions we need to ask to rebuild a better healthcare system. 

About Chris McCabe

Dr. Christopher McCabe is Professor of Health Economics at Queens University

Belfast, jointly appointed to the Faculty of Medicine, Health and Life Sciences

and Queens Management School. He was previously the CEO and Executive Director

of the Institute of Health Economics, a not-for-profit research institute in

Alberta Canada.

Dr. McCabe has 30 years’ experience as a university based health economist.

He trained and worked for 20 years in the UK before emigrating to Canada. His

PhD was concerned with the methods for valuing paediatric health. During his

time in the UK, he held Full Professorships at the Universities of Sheffield,

Warwick and Leeds. In the United Kingdom he was the founding Director of both

the NICE Decision Support Unit, and the Academic Unit of Health Economics at

the University of Leeds. He was more recently a Professor of Health Economics

at the University of Alberta, where he was appointed to the Capital Health

Endowed Research Chair.

Dr. McCabe has contributed to a number of standard setting documents related

to the evaluation of innovative health technologies including the second

edition of the NICE Guide to the Methods of Health Technology Appraisal, the

fourth edition of the CADTH Guidelines for the Economic Evaluation of Health

Technologies, and third edition of the ISSC Guidelines for the translation of

stem cell research and regenerative medicine. He was lead author of the 2018

CADTH Guideline on the economic evaluation of co-dependent therapies. He has

contributed key papers to the literature the reimbursement of treatments for

rare diseases. More recently Dr. McCabe advised the Patented Medicines Price

Review Board on the technical issues related to the revision of their

regulations for setting the price of patented drugs in Canada. He is currently

Chair of the Royal Society of Canada COVID Task Force Working Group on the

Economy, and a member of the same task force’s Working Group on Health Care

post-COVID.

Helpful Links

Chris McCabe | LinkedIn: Click Here 

Tell Us What You Think

We welcome your feedback about the HQ Podcast so we can continuously improve

and create episodes that our listeners want to hear.

Please take a few moments to fill out our short survey: Click Here

Don't forget to subscribe to The HQ on your favourite podcast player and

leave us a review!